Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Clinical Transplants
|
August 19, 2015
Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry
Elaine Y Cheng, Matthew J Everly
Seminars in Immunology
|
December 14, 2011
The state of therapy for removal of alloantibody producing plasma cells in transplantation
Matthew J Everly, Paul I Terasaki
Clinical Transplants
|
June 8, 2010
Heart transplantation in the United States from 1998 to 2008
Mepur H Ravindranath, Matthew J Everly
Human Immunology
|
April 21, 2009
Monitoring and treating posttransplant human leukocyte antigen antibodies
Matthew J Everly, Paul I Terasaki
Clinical Transplants
|
May 18, 2017
An Update on Cardiac Transplantation in the United States Based on an Analysis of the UNOS Registry
Juhi R Khatiwala, Matthew J Everly
The Annals of Pharmacotherapy
|
January 27, 2004
Beta-blocker underuse in secondary prevention of myocardial infarction
Matthew J Everly, Pamela C Heaton, Robert J Cluxton
Chinese Medical Journal
|
April 27, 2011
Role of proteasome inhibition in sensitized transplant candidates
Matthew J Everly, Jason J Everly, Paul I Terasaki
Transplantation
|
January 21, 2012
Durability of antibody removal following proteasome inhibitor-based therapy
Matthew J Everly, Paul I Terasaki, Hargovind L Trivedi
Scientific Reports
|
October 28, 2020
Personalized prediction of delayed graft function for recipients of deceased donor kidney transplants with machine learning
Satoru Kawakita, Jennifer L Beaumont, Vadim Jucaud, et al.
Transplantation
|
August 22, 2009
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss
Po-Chang Lee, Lan Zhu, Paul I Terasaki, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Clinical Transplants
|
August 19, 2015
Trends of Immunosuppression and Outcomes Following Liver Transplantation: An Analysis of the United Network for Organ Sharing Registry
Elaine Y Cheng, Matthew J Everly
Seminars in Immunology
|
December 14, 2011
The state of therapy for removal of alloantibody producing plasma cells in transplantation
Matthew J Everly, Paul I Terasaki
Clinical Transplants
|
June 8, 2010
Heart transplantation in the United States from 1998 to 2008
Mepur H Ravindranath, Matthew J Everly
Human Immunology
|
April 21, 2009
Monitoring and treating posttransplant human leukocyte antigen antibodies
Matthew J Everly, Paul I Terasaki
Clinical Transplants
|
May 18, 2017
An Update on Cardiac Transplantation in the United States Based on an Analysis of the UNOS Registry
Juhi R Khatiwala, Matthew J Everly
The Annals of Pharmacotherapy
|
January 27, 2004
Beta-blocker underuse in secondary prevention of myocardial infarction
Matthew J Everly, Pamela C Heaton, Robert J Cluxton
Chinese Medical Journal
|
April 27, 2011
Role of proteasome inhibition in sensitized transplant candidates
Matthew J Everly, Jason J Everly, Paul I Terasaki
Transplantation
|
January 21, 2012
Durability of antibody removal following proteasome inhibitor-based therapy
Matthew J Everly, Paul I Terasaki, Hargovind L Trivedi
Scientific Reports
|
October 28, 2020
Personalized prediction of delayed graft function for recipients of deceased donor kidney transplants with machine learning
Satoru Kawakita, Jennifer L Beaumont, Vadim Jucaud, et al.
Transplantation
|
August 22, 2009
HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss
Po-Chang Lee, Lan Zhu, Paul I Terasaki, et al.
Page
of 7